跳至主要内容
临床试验/DRKS00024555
DRKS00024555已完成未知

Enhancing the satisfaction with prostate cancer treatment decision with the mHealth progam PROSTANA®: A multicenter randomized controlled trial - EasiPRO3

Ferring Arzneimittel GmbH0 个研究点目标入组 244 人开始时间: 2021年3月4日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
244

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 one(—)
性别
Male

入选标准

  • Minimum age of 18 years
  • - Patients in the participating centers
  • - Initial diagnosis of PCa (ICD-10 code C61)
  • - Access to internet-enabled devices
  • - Classified by physician as capable of participating in the study
  • - Existing participation forms

排除标准

  • - Under 18 years
  • - Patients who are already in treatment
  • - Patients for whom the treatment of a comorbidity is absolutely paramount on basis of the treating urologist

研究者

相似试验